Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
While waiting for an efficient vaccine to protect against SARS-CoV-2 infection, alternative approaches to treat or prevent acute COVID-19 are urgently needed. Transfusion of convalescent plasma to treat COVID-19 patients is currently being explored; neutralizing activity in convalescent plasma is thought to play a central role in the efficacy of this treatment. Here, we observed that plasma neutralization activity decreased a few weeks after the onset of the symptoms. If neutralizing activity is required for the efficacy of convalescent plasma transfer, our results suggest that convalescent plasma should be recovered rapidly after the donor recovers from active infection.
Article activity feed
-
-
SciScore for 10.1101/2020.07.09.194639: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Ethics statement: All work was conducted in accordance with the Declaration of Helsinki in terms of informed consent and approval by an appropriate institutional board. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication Authentication: The presence of the desired mutations was determined by automated DNA sequencing. Table 2: Resources
Antibodies Sentences Resources Horseradish peroxidase (HRP)-conjugated antibody specific for the Fc region of human IgG (Invitrogen) or for the Fc region of human IgM (Jackson ImmunoResearch Laboratories, inc.) were used as secondary … SciScore for 10.1101/2020.07.09.194639: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Ethics statement: All work was conducted in accordance with the Declaration of Helsinki in terms of informed consent and approval by an appropriate institutional board. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication Authentication: The presence of the desired mutations was determined by automated DNA sequencing. Table 2: Resources
Antibodies Sentences Resources Horseradish peroxidase (HRP)-conjugated antibody specific for the Fc region of human IgG (Invitrogen) or for the Fc region of human IgM (Jackson ImmunoResearch Laboratories, inc.) were used as secondary antibodies to detect antibody binding in ELISA experiments. human IgGsuggested: NoneExperimental Models: Cell Lines Sentences Resources 293T-ACE2 cell line was previously reported (3). 293T-ACE2suggested: RRID:CVCL_YZ65)Flow cytometry analysis of cell-surface staining: Using the standard calcium phosphate method, 10μg of Spike expressor and 2μg of a green fluorescent protein (GFP) expressor (pIRES-GFP) were transfected into 2 × 106 293T cells. 293Tsuggested: NCBI_Iran Cat# C498, RRID:CVCL_0063)Software and Algorithms Sentences Resources Samples were acquired on a LSRII cytometer (BD Biosciences, Mississauga, ON, Canada) and data analysis was performed using FlowJo vX. FlowJosuggested: (FlowJo, RRID:SCR_008520)Statistical analyses: Statistics were analyzed using GraphPad Prism version 8.0.2 (GraphPad, San Diego, CA, (USA). GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-